Choice or chance: the social context of contraceptive use by women with HCV and their reproductive & sexual health needs

选择还是机会：HCV 女性使用避孕药具的社会背景及其生殖能力

• 批准号: nhmrc : 268011
• 负责人: A/Pr Cathy Banwell
• 金额: $ 17.35万
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Project Grants
• 财政年份: 2004
• 资助国家: 澳大利亚
• 起止时间: 2004-01-01 至 2005-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/choice-chance-social-health-needs/96954
• 关键词: Choice; chance; social; context; contraceptive

Hepatitis C is a growing health concern, with 1% of the Australian population now HCV positive, and signs that it is increasing more quickly among women of child-bearing age. This study builds upon recent research that shows that Australia women with Hepatitis C have low levels of contraception even though they have specific contraceptive needs relating to concerns about the risks of vertical transmission, the effects of the diease on their children and the use of Ribavirin, a teratogen, in HCV treatment. This study aims to elucidate the reasons for this low level of contraception among women with Hepatitis C through interviews with them (and in some cases their partners) about the complex array of practices and understandings, within the contexts of their lives, that influence their contraceptive and reproductive behaviours. The public health outcomes of this research include the development of contraceptive information that is relevant to the specific needs of women with Hepatitis C and the identification of barriers to family planning and reproductive health services for these women.

丙型肝炎是一个日益严重的健康问题，目前澳大利亚有1%的人口呈丙型肝炎病毒阳性，而且有迹象表明，在育龄妇女中，丙型肝炎病毒的增加速度更快。这项研究建立在最近的研究基础上，该研究表明，澳大利亚丙型肝炎妇女的避孕水平很低，尽管她们有特殊的避孕需求，涉及到对垂直传播风险的担忧、疾病对子女的影响以及在丙型肝炎治疗中使用利巴韦林（一种致畸剂）。本研究旨在通过对丙型肝炎妇女（在某些情况下是其伴侣）进行访谈，了解影响其避孕和生殖行为的生活背景下的一系列复杂做法和理解，阐明丙型肝炎妇女避孕水平低的原因。这项研究的公共卫生成果包括制定与丙型肝炎妇女的具体需要有关的避孕信息，并查明为这些妇女提供计划生育和生殖健康服务的障碍。